Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
02/2012
02/21/2012CA2412460C Human monoclonal antibody against hepatitis c virus e2 glycoprotein
02/21/2012CA2398940C Methods and compositions using stearoyl-coa desaturase to identify triglyceride reducing therapeutic agents
02/21/2012CA2394716C Hydrolytically degradable carbamate derivatives of poly(ethylene glycol)
02/21/2012CA2297303C Novel peptides and polypeptides useful for regenerating the nervous system
02/21/2012CA2263835C Stimulus-inducible i (kappa)b kinase [ikk] signalsome
02/16/2012WO2012020813A1 Fused-ring pyrrolidine derivative
02/16/2012WO2012020795A1 Nucleic acid/polysaccharide complex
02/16/2012WO2012020787A1 Malignant lymphoma therapeutic agent
02/16/2012WO2012020786A1 Pharmaceutical composition
02/16/2012WO2012020785A1 Medicinal agent for prevention and/or treatment of hepatocellular carcinoma
02/16/2012WO2012020780A1 Heterocyclic compound and use thereof
02/16/2012WO2012020767A1 Pyrroloquinoline quinone gel
02/16/2012WO2012020762A1 Hetero ring compound
02/16/2012WO2012020749A1 Triazine derivative and pharmaceutical compound that contains same and exhibits analgesic activity
02/16/2012WO2012020742A1 Novel heterocyclic derivatives and pharmaceutical composition containing same
02/16/2012WO2012020738A1 Heterocyclic compound and use thereof
02/16/2012WO2012020726A1 Inhibitor of casein kinase 1δ and casein kinase 1ε
02/16/2012WO2012020725A1 Heterocyclic derivative having npy y5 receptor antagonism
02/16/2012WO2012020567A1 Acyl piperazine derivatives as ttx-s blockers
02/16/2012WO2012019428A1 Benzohydrol derivatives, a preparation process and pharmaceutical use thereof
02/16/2012WO2012019427A1 Phthalazinone ketone derivative, preparation method thereof, and pharmaceutical use thereof
02/16/2012US20120041524 Compositions for Providing Vitamin D Year Round and Uses Thereof
02/16/2012US20120041067 Methods of Inducing Terminal Differentiation
02/16/2012US20120041060 Treatment for altitudinal hypoxia
02/16/2012US20120041053 DELIVERY OF dsRNA TO ARTHROPODS
02/16/2012US20120041010 Pharmaceutical combination of (e)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl] (3r,5s)-3,5-dihydroxyhept-6-enoic acid and candesartan
02/16/2012US20120041005 Use of alkanoyl l-carnitine for the treatment of erectile dysfunction
02/16/2012US20120040994 THERAPEUTIC AGENT FOR GLAUCOMA COMPRISING Rho KINASE INHIBITOR AND PROSTAGLANDIN
02/16/2012US20120040933 9-(piperazinylalkyl) carbazoles as bax-modulators
02/16/2012US20120040925 Aryl urea compounds in combination with other cytostatic or cytotoxic agents for treating human cancers
02/16/2012US20120040916 Molecular inhibitors of the wnt/beta-catenin pathway
02/16/2012US20120040913 Methods and compositions for treating diabetes
02/16/2012US20120040901 Novel biomaterials, their preparation and use
02/16/2012US20120040897 Novel derivatives of acyl cyanopyrrolidines
02/16/2012US20120040829 Bacterial ghosts as carrier and targeting vehicles
02/16/2012US20120040024 Methods and compositions for enhancing survivability of cells, tissues, organs and organisms
02/16/2012US20120040019 Medicated ointment for treating hemorrhoid and method of using the same
02/16/2012US20120040013 Regenerative Tissue Scaffolds
02/16/2012US20120040004 Treatment of radiation-induced fibrosis
02/16/2012US20120040002 Resorbable and biocompatible fibre glass compositions and their uses
02/16/2012US20120039987 Niosome having metal porphyrin complex embedded therein, process for producing the same and drug with the use thereof
02/16/2012US20120039985 Dendritic cell modulation in post-ischemic wounds
02/16/2012US20120039969 Swellable dosage form comprising gellan gum
02/16/2012US20120039959 Anti-Adhesion Alginate Barrier of Variable Absorbance
02/16/2012US20120039944 Whey and thymus function
02/16/2012US20120039931 Dna composition encoding an immunogenic vegf receptor peptide and methods of use thereof
02/16/2012US20120039885 Composition and method for cancer treatment
02/16/2012US20120039880 FRAGMENTATION RESISTANT IgG1 Fc-CONJUGATES
02/16/2012US20120039874 Human monoclonal antibody against a costimulatory signal transduction molecule ailim and pharmaceutical use thereof
02/16/2012US20120039839 Hypoxia Induced Mitogenic Factor
02/16/2012US20120039815 Contrast agents
02/16/2012US20120039814 Topical Compositions and Methods of Detection and Treatment
02/16/2012CA2808435A1 Heterocyclic compound
02/16/2012CA2807947A1 Triazine derivative and pharmaceutical compound that contains same and exhibits analgesic activity
02/16/2012CA2807359A1 Inhibitor of casein kinase 1.delta. and casein kinase 1.epsilon.
02/16/2012CA2806324A1 Phthalazinone ketone derivative, preparation method thereof, and pharmaceutical use thereof
02/15/2012EP2418208A1 Inhibitor for elevation of gip level
02/15/2012EP2417985A1 Mitochondrial function-improving agent
02/15/2012EP2416804A2 Amatoxin-armed therapeutic cell surface binding components designed for tumour therapy
02/15/2012EP2416776A2 Use of tetrahydrobiopterin as a marker and a therapeutic agent for fabry disease
02/15/2012EP2416767A2 Compositions and methods for bioactive coatings to improve allograft incorporation
02/15/2012CN102356152A Process for producing lactic acid bacterium having enhanced immunomodulating activity
02/15/2012CN102356085A Imidazothiazole derivative having proline ring structure
02/15/2012CN102356061A Method for producing bicyclic g-amino acid derivative
02/15/2012CN102355884A Agent for preventing, inhibiting, or ameliorating skin aging due to buildup of advanced glycation end products
02/15/2012CN102349997A Diagnosis and prevention of cancer cell invasion
02/15/2012CN102349950A Food, health product or pharmaceutical composition as well as preparation method and application thereof
02/15/2012CN102349903A New pharmaceutical composition containing levoamlodipine and valsartan and preparation method thereof
02/14/2012US8115027 NPY Y5 antagonist
02/14/2012US8114999 Aminocarbonyl-derivatives as novel inhibitors of histone deacetylase
02/14/2012US8114997 N4-acylcytosine nucleosides for treatment of viral infections
02/14/2012US8114965 Compositions of PSMA antibodies
02/14/2012US8114896 Method and composition for potentiating an opiate analgesic
02/14/2012US8114838 Methods for protecting dopaminergic neurons from stress and promoting proliferation and differentiation of oligodendrocyte progenitors by NRG-2
02/14/2012US8114835 Microtexture matrix comprising diacetylene conjugated amino acid sequences for use in propagation of preferential tissues; drug screening
02/14/2012US8114834 Self-assembling peptide amphiphiles
02/14/2012US8114831 Guanylate cyclase receptor agonists for the treatment of tissue inflammation and carcinogenesis
02/14/2012US8114603 collecting a blood sample from the subject; andmeasuring the levels of Triggering Receptor Expressed on Myeloid cells (TREM-1) splice variant protein in sample, a decrease in the levels of TREM-1 splice variant indicates an inflammatory response
02/14/2012CA2651653C 6-alkenyl-, 6-alkinyl- and 6-epoxy-epothilone derivatives, process for their production, and their use in pharmaceutical preparations
02/14/2012CA2463154C Heterocyclic compounds and methods of use
02/09/2012WO2012019113A2 Inhibitors of erk for developmental disorders of neuronal connectivity
02/09/2012WO2012018127A1 Islets of langerhans transplant using islets of langerhans and adipose tissue derived stem cells
02/09/2012WO2012018115A1 Composition for regeneratng normal tissue from fibrotic tissue
02/09/2012WO2012018069A1 Preparation for treatment of spinal cord injury
02/09/2012WO2012018065A1 Process for preparing compound having hiv integrase inhibitory activity
02/09/2012WO2012018059A1 Heterocyclic compound
02/09/2012WO2012018058A1 Fused heterocyclic ring compound
02/09/2012WO2012017932A1 Process for preparing compound by novel sandmeyer-like reaction using nitroxide radical compound as reaction catalyst
02/09/2012WO2012017876A1 P2x4 receptor antagonist
02/09/2012WO2012017555A1 Elastase inhibitor
02/09/2012WO2012017451A1 A bio-stabilized resveratrol formulation
02/09/2012WO2012017119A2 Non-viral vectors for gene therapy
02/09/2012WO2012016691A1 Use of glyceryl trinitrate for treating traumatic edema
02/09/2012US20120035257 Histone Deacetylase Inhibitors
02/09/2012US20120035253 Crystalline forms of genistein
02/09/2012US20120035222 Solid forms of 2-Chloro-4-[1-(4-fluoro-phenyl)-2,5-dimethyl-1H-imidazol-4-ylethynyl]-pyridine
02/09/2012US20120035217 Bis Aromatic Compounds for Use as LTC4 Synthase Inhibitors
02/09/2012US20120035202 Rifaximin compositions and method of use
02/09/2012US20120035164 Chemical compounds
02/09/2012US20120035129 Hydrogel tissue adhesive having reduced degradation time
1 ... 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 ... 1564